Accessibility Menu
 
AbbVie logo

AbbVie

(NYSE) ABBV

Current Price$198.46
Market Cap$349.12B
Since IPO (2012)+870%
5 Year+113%
1 Year+10%
1 Month-5%

AbbVie Financials at a Glance

Market Cap

$349.12B

Revenue (TTM)

$61.16B

Net Income (TTM)

$4.23B

EPS (TTM)

$2.36

P/E Ratio

83.59

Dividend

$6.74

Beta (Volatility)

0.34 (Low)

Price

$198.46

Volume

71,030

Open

$198.88

Previous Close

$197.38

Daily Range

$196.86 - $199.17

52-Week Range

$176.57 - $244.81

ABBV: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AbbVie

Industry

Biotechnology

Employees

57,000

CEO

Robert A. Michael, MBA, CPA

Headquarters

North Chicago, IL 60064-6400, US

ABBV Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

27%

Net Income Margin

7%

Return on Equity

15222%

Return on Capital

18%

Return on Assets

3%

Earnings Yield

1.20%

Dividend Yield

3.41%

Payout Ratio

2.76%

Stock Overview

Market Cap

$349.12B

Shares Outstanding

1.77B

Volume

71.03K

Avg. Volume

7.10M

Financials (TTM)

Gross Profit

$42.96B

Operating Income

$20.09B

EBITDA

$17.63B

Operating Cash Flow

$19.03B

Capital Expenditure

$1.21B

Free Cash Flow

$17.82B

Cash & ST Invst.

$5.26B

Total Debt

$69.07B

AbbVie Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$16.62B

+10.0%

Gross Profit

$12.07B

+12.7%

Gross Margin

72.61%

N/A

Market Cap

$349.12B

N/A

Market Cap/Employee

$6.35M

N/A

Employees

55,000

N/A

Net Income

$1.82B

+8354.5%

EBITDA

$5.37B

+903.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$63.62B

-2.1%

Accounts Receivable

$12.59B

+15.3%

Inventory

$4.95B

+18.4%

Long Term Debt

$60.32B

-1.2%

Short Term Debt

$8.55B

+25.7%

Return on Assets

3.15%

N/A

Return on Invested Capital

18.02%

N/A

Free Cash Flow

$4.89B

-27.6%

Operating Cash Flow

$5.22B

-26.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UNHUnitedHealth Group Incorporated
$365.19+2.96%
AZNAstraZeneca PLC
$187.13-0.20%
NVSNovartis AG
$144.75+0.39%
MRKMerck & Co., Inc.
$111.43+1.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$11.03+0.03%
POETPoet Technologies
$7.78-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.08-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$59.88-0.04%

Questions About ABBV

What is the current price of AbbVie?

AbbVie is trading at $198.39 per share.

What is the 52-week range for AbbVie?

Over the past 52 weeks, AbbVie has traded between $176.57 and $244.81.

How much debt does AbbVie have?

As of the most recent reporting period, AbbVie reported total debt of $68.19B.

How much cash does AbbVie have on hand?

AbbVie reported $5.23B in cash and cash equivalents in its most recent financial results.

What is AbbVie’s dividend yield?

AbbVie currently has a dividend yield of 3.41%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.